Selected article for: "clinical study and lung cancer"
Author: Bertaglia, Valentina; Reale, Maria Lucia; Bironzo, Paolo; Palesandro, Erica; Mariniello, Annapaola; Leone, Gianmarco; Tabbò, Fabrizio; Bungaro, Maristella; Audisio, Marco; Rapetti, Simonetta; Di Stefano, Rosario Francesco; Carnio, Simona; Artusio, Elisa; Capelletto, Enrica; Sperone, Paola; Passiglia, Francesco; Novello, Silvia
Title: Italian Survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: a lesson for the second wave
  • Cord-id: m3i5314b
  • Document date: 2020_11_27
    • ID: m3i5314b
    Snippet: This study investigated the clinical management of non small cell lung cancer (NSCLC) patients during the first wave of coronavirus disease 2019 (COVID-19) outbreak in Italy. A 29-questions survey was sent to 95 Italian thoracic oncologists, with 77% of them declaring significant changes in the outpatients management and treatment. The results of this survey pointed out a significant delay of lung cancer diagnosis along with a relevant reduction of patients’ accrual within clinical trials, whi
    Document: This study investigated the clinical management of non small cell lung cancer (NSCLC) patients during the first wave of coronavirus disease 2019 (COVID-19) outbreak in Italy. A 29-questions survey was sent to 95 Italian thoracic oncologists, with 77% of them declaring significant changes in the outpatients management and treatment. The results of this survey pointed out a significant delay of lung cancer diagnosis along with a relevant reduction of patients’ accrual within clinical trials, while telemedicine emerged as a valid support for patient-healthcare interactions. Therapeutic indications followed the guidelines for adjuvant chemotherapy and concurrent chemo-radiation. Clinical indications to first-line therapies were largely confirmed, while major changes regarded the selection of second line treatment options as well as the management of elderly population. This work may represent a valid source of information to improve the clinical management of NSCLC patients during second wave of COVID-19 pandemic.

    Search related documents:
    Co phrase search for related documents
    • active treatment and locally advanced disease: 1, 2
    • active treatment and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • active treatment and lung cancer diagnosis: 1
    • active treatment follow and lung cancer: 1, 2, 3
    • adequately address and low access: 1
    • administration interval and lung cancer: 1
    • locally advanced and low toxicity profile: 1, 2
    • locally advanced and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • locally advanced and lung cancer diagnosis: 1
    • locally advanced disease and low toxicity profile: 1
    • locally advanced disease and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8
    • locally advanced disease and lung cancer diagnosis: 1
    • low access and lung cancer: 1, 2